CY1109660T1 - Η χρηση της οξυκωδονης για την θεραπευτικη αντιμετωπιση του σπλαγχνικου πονου - Google Patents
Η χρηση της οξυκωδονης για την θεραπευτικη αντιμετωπιση του σπλαγχνικου πονουInfo
- Publication number
- CY1109660T1 CY1109660T1 CY20091101308T CY091101308T CY1109660T1 CY 1109660 T1 CY1109660 T1 CY 1109660T1 CY 20091101308 T CY20091101308 T CY 20091101308T CY 091101308 T CY091101308 T CY 091101308T CY 1109660 T1 CY1109660 T1 CY 1109660T1
- Authority
- CY
- Cyprus
- Prior art keywords
- visceral pain
- oxycodone
- therapeutic treatment
- administration
- effectively treated
- Prior art date
Links
- 208000009935 visceral pain Diseases 0.000 title abstract 4
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 title abstract 3
- 229960002085 oxycodone Drugs 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 2
- 229940127240 opiate Drugs 0.000 abstract 2
- 230000001154 acute effect Effects 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64549005P | 2005-01-18 | 2005-01-18 | |
| EP06700652A EP1838318B1 (en) | 2005-01-18 | 2006-01-17 | Use of oxycodone for treating visceral pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1109660T1 true CY1109660T1 (el) | 2014-08-13 |
Family
ID=35871217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091101308T CY1109660T1 (el) | 2005-01-18 | 2009-12-16 | Η χρηση της οξυκωδονης για την θεραπευτικη αντιμετωπιση του σπλαγχνικου πονου |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US20080200493A1 (enExample) |
| EP (1) | EP1838318B1 (enExample) |
| JP (1) | JP5049139B2 (enExample) |
| KR (10) | KR20200128451A (enExample) |
| CN (1) | CN101106996B (enExample) |
| AP (1) | AP2249A (enExample) |
| AR (1) | AR052880A1 (enExample) |
| AT (2) | ATE446092T1 (enExample) |
| AU (1) | AU2006207498B2 (enExample) |
| BR (1) | BRPI0606247A2 (enExample) |
| CA (1) | CA2595043C (enExample) |
| CY (1) | CY1109660T1 (enExample) |
| DE (2) | DE602006009899D1 (enExample) |
| DK (2) | DK1838318T3 (enExample) |
| EA (1) | EA013544B1 (enExample) |
| ES (1) | ES2333901T3 (enExample) |
| HR (1) | HRP20090679T1 (enExample) |
| IL (1) | IL184530A (enExample) |
| ME (1) | ME01066B (enExample) |
| MX (1) | MX2007007207A (enExample) |
| MY (1) | MY144471A (enExample) |
| NO (1) | NO338968B1 (enExample) |
| NZ (1) | NZ555852A (enExample) |
| PL (1) | PL1838318T3 (enExample) |
| PT (1) | PT1838318E (enExample) |
| RS (1) | RS51069B (enExample) |
| SI (1) | SI1838318T1 (enExample) |
| TW (1) | TWI432196B (enExample) |
| UA (1) | UA85471C2 (enExample) |
| WO (1) | WO2006077212A1 (enExample) |
| ZA (1) | ZA200705231B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3045182T3 (en) | 2005-11-14 | 2018-03-19 | Teva Pharmaceuticals Int Gmbh | ANTAGONIST ANTIBODIES AGAINST CALCITONIN GEN-RELATED PEPTIDE TO TREAT HEAT |
| WO2008148798A2 (en) | 2007-06-04 | 2008-12-11 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
| WO2009109911A1 (en) | 2008-03-04 | 2009-09-11 | Pfizer Limited | Methods of treating chronic pain |
| CA2751667C (en) | 2009-02-06 | 2016-12-13 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
| EP2445487A2 (en) | 2009-06-24 | 2012-05-02 | Egalet Ltd. | Controlled release formulations |
| RU2535074C2 (ru) * | 2009-08-28 | 2014-12-10 | Лэйбрис Байолоджикс, Инк. | Способы лечения висцеральной боли путем введения антител-антагонистов, направленных против пептида, связанного с геном кальцитонина |
| TWI692485B (zh) | 2011-05-20 | 2020-05-01 | 美商艾爾德生物控股有限責任公司 | 抗降血鈣素基因相關胜肽（ａｎｔｉ-ｃｇｒｐ）組成物及其用途 |
| CN103702685B (zh) | 2011-05-20 | 2017-12-15 | 奥尔德生物控股有限责任公司 | 抗cgrp抗体和抗体片段用于在有需要的受试者、尤其是偏头痛患者中预防或抑制畏光或厌光的用途 |
| KR102128628B1 (ko) | 2011-05-20 | 2020-06-30 | 앨더바이오 홀딩스 엘엘씨 | 설사의 만성 및 급성 형태를 치료 또는 예방하기 위한 항-cgrp 또는 항-cgrp-r 항체 또는 항체 단편의 용도 |
| US20170114122A1 (en) | 2015-10-23 | 2017-04-27 | Alderbio Holdings Llc | Regulation of glucose metabolism using anti-cgrp antibodies |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| RS65360B1 (sr) | 2014-03-21 | 2024-04-30 | Teva Pharmaceuticals Int Gmbh | Antagonistička antitela specifična za peptid genski srodan kalcitoninu i postupci njihove upotrebe |
| AU2017331593B2 (en) | 2016-09-23 | 2022-04-28 | Teva Pharmaceuticals International Gmbh | Treating refractory migraine |
| JP7472116B2 (ja) | 2018-11-19 | 2024-04-22 | ジャズ ファーマシューティカルズ アイルランド リミテッド | 耐アルコール性製剤 |
| US11639380B2 (en) | 2019-01-08 | 2023-05-02 | H. Lundbeck A/S | Acute treatment and rapid treatment of headache using anti-CGRP antibodies |
| SG10202003296VA (en) | 2020-04-06 | 2021-11-29 | H Lundbeck As | Treatment of most bothersome symptom (mbs) associated with migraine using anti-cgrp antibodies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5656295A (en) * | 1991-11-27 | 1997-08-12 | Euro-Celtique, S.A. | Controlled release oxycodone compositions |
| US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
| US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
| IL110014A (en) * | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
| US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| CN1494907A (zh) * | 1996-03-25 | 2004-05-12 | 治疗疼痛的药物组合物 | |
| UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| US6992193B2 (en) * | 2003-06-10 | 2006-01-31 | Adolor Corporation | Sulfonylamino phenylacetamide derivatives and methods of their use |
-
2006
- 2006-01-05 TW TW095100458A patent/TWI432196B/zh not_active IP Right Cessation
- 2006-01-09 MY MYPI20060082A patent/MY144471A/en unknown
- 2006-01-17 KR KR1020207031796A patent/KR20200128451A/ko not_active Ceased
- 2006-01-17 AP AP2007004057A patent/AP2249A/xx active
- 2006-01-17 RS RSP-2009/0553A patent/RS51069B/sr unknown
- 2006-01-17 ES ES06700652T patent/ES2333901T3/es active Active
- 2006-01-17 KR KR1020077018905A patent/KR20070100368A/ko not_active Ceased
- 2006-01-17 CA CA2595043A patent/CA2595043C/en active Active
- 2006-01-17 BR BRPI0606247-4A patent/BRPI0606247A2/pt not_active Application Discontinuation
- 2006-01-17 UA UAA200708142A patent/UA85471C2/ru unknown
- 2006-01-17 SI SI200630538T patent/SI1838318T1/sl unknown
- 2006-01-17 PL PL06700652T patent/PL1838318T3/pl unknown
- 2006-01-17 KR KR1020227041445A patent/KR20220165797A/ko not_active Ceased
- 2006-01-17 MX MX2007007207A patent/MX2007007207A/es active IP Right Grant
- 2006-01-17 DK DK06700652T patent/DK1838318T3/da active
- 2006-01-17 KR KR1020147018838A patent/KR20140091782A/ko not_active Ceased
- 2006-01-17 KR KR1020237042001A patent/KR20230170811A/ko not_active Ceased
- 2006-01-17 KR KR1020177004572A patent/KR20170021905A/ko not_active Ceased
- 2006-01-17 KR KR1020127011713A patent/KR20120089710A/ko not_active Ceased
- 2006-01-17 AU AU2006207498A patent/AU2006207498B2/en active Active
- 2006-01-17 PT PT06700652T patent/PT1838318E/pt unknown
- 2006-01-17 JP JP2007550797A patent/JP5049139B2/ja not_active Expired - Fee Related
- 2006-01-17 NZ NZ555852A patent/NZ555852A/en unknown
- 2006-01-17 EP EP06700652A patent/EP1838318B1/en active Active
- 2006-01-17 CN CN2006800024739A patent/CN101106996B/zh active Active
- 2006-01-17 WO PCT/EP2006/050252 patent/WO2006077212A1/en not_active Ceased
- 2006-01-17 EA EA200701541A patent/EA013544B1/ru not_active IP Right Cessation
- 2006-01-17 KR KR1020217034339A patent/KR20210131450A/ko not_active Ceased
- 2006-01-17 DE DE602006009899T patent/DE602006009899D1/de active Active
- 2006-01-17 ME MEP-2009-352A patent/ME01066B/me unknown
- 2006-01-17 US US11/814,020 patent/US20080200493A1/en not_active Abandoned
- 2006-01-17 KR KR1020087029312A patent/KR20080106991A/ko not_active Ceased
- 2006-01-17 HR HR20090679T patent/HRP20090679T1/hr unknown
- 2006-01-17 KR KR1020197035201A patent/KR20190135557A/ko not_active Ceased
- 2006-01-17 DE DE202006019887U patent/DE202006019887U1/de not_active Expired - Lifetime
- 2006-01-17 AT AT06700652T patent/ATE446092T1/de active
- 2006-01-18 AR ARP060100177A patent/AR052880A1/es unknown
-
2007
- 2007-03-09 AT AT0014807U patent/AT9895U1/de not_active IP Right Cessation
- 2007-07-02 ZA ZA200705231A patent/ZA200705231B/xx unknown
- 2007-07-10 IL IL184530A patent/IL184530A/en active IP Right Grant
- 2007-07-24 DK DK200700207U patent/DK200700207U3/da not_active IP Right Cessation
- 2007-08-14 NO NO20074174A patent/NO338968B1/no not_active IP Right Cessation
-
2009
- 2009-12-16 CY CY20091101308T patent/CY1109660T1/el unknown
-
2014
- 2014-10-15 US US14/515,216 patent/US9271974B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109660T1 (el) | Η χρηση της οξυκωδονης για την θεραπευτικη αντιμετωπιση του σπλαγχνικου πονου | |
| CY1106697T1 (el) | Ν-υποκατεστημενες υδρομορφονες και η χρηση αυτων | |
| TW200738725A (en) | Unsaturated mTOR inhibitors | |
| EA200802412A1 (ru) | Терапевтические комбинации для сопровождающихся болью медицинских состояний | |
| TR201900306T4 (tr) | Mek inhibitörlerini kullanma yöntemleri. | |
| EA200970932A1 (ru) | Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа | |
| EA200970935A1 (ru) | Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа | |
| CY1106589T1 (el) | (s)-2-ν-προπυλαμινο-5-υδροξυτετραλινη ως d3-αγωνιστικο θεραπευτικο μεσο | |
| TW200801006A (en) | Fused bicyclic mTOR inhibitors | |
| EA200900615A1 (ru) | Фенилпропионамидные соединения и их применение | |
| EA201300465A1 (ru) | Устойчивые оральные фармацевтические дозированные формы, содержащие опиоидный анальгетик | |
| MX374396B (es) | Rocio de fentanilo sublingual. | |
| EA200500859A1 (ru) | Хинолинилпирролопиразолы | |
| CY1120433T1 (el) | Θεραπεια αγωνιστων μελατονινης | |
| CY1106476T1 (el) | Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες | |
| BRPI0415709A (pt) | esquemas terapêuticos para antagonistas de baff | |
| NZ600379A (en) | Morphinan derivatives for the treatment of drug overdose | |
| BRPI0908635B8 (pt) | composto e/ou um sal farmaceuticamente aceitável do mesmo e composição farmacêutica | |
| MX2007008756A (es) | Uso de metilnaltrexona y compuestos relacionados para el tratamiento de disfuncion gastrointestinal postoperatoria. | |
| CY1109840T1 (el) | Σπινοσινες για επουλωση πληγων | |
| CY1109031T1 (el) | Τριαζασπιρο ενωσεις χρησιμες για την αντιμετωπιση ή προληψη πονου | |
| CY1110366T1 (el) | Ασεναπινη για τη θεραπεια της σχιζοφρενειας σε ενα υπερβαρο ασθενη ή που εχει προδιαθεση να γινει υπερβαρος | |
| TR201002473A2 (tr) | Herpes zoster hastalığının bır opiat reseptör antagonist kullanılarak tedavi yöntemi. | |
| EA201170821A1 (ru) | Энзастаурин для лечения рака | |
| DE602005011113D1 (de) | Morphinanderivate als mittel gegen juckreiz |